Absci (ABSI) Other Non-Current Assets (2021 - 2026)
Absci (ABSI) reported Other Non-Current Assets of $1.1 million for Q1 2026, up 68.3% on a YoY basis from $631000.0 in Q1 2025, and up 0.85% sequentially from $1.1 million in Q4 2025.
Absci (ABSI) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Absci (ABSI) has 6 years of Other Non-Current Assets data on file, last reported at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 68.3% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 68.3% YoY), and the FY2025 full-year result was $1.1 million, down 93.4% from the prior year.
- Other Non-Current Assets grew to $1.1 million in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $16.5 million in Q2 2024 to a low of $631000.0 in Q1 2025.
- A 5-year average of $4.8 million and a median of $1.6 million in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets soared 937.54% in 2024 and sank 95.66% in 2025, its largest moves.
- Tracing ABSI's Other Non-Current Assets over 5 years: stood at $1.9 million in 2022, then slipped by 17.54% to $1.5 million in 2023, then soared by 937.54% to $15.9 million in 2024, then tumbled by 93.4% to $1.1 million in 2025, then increased by 0.85% to $1.1 million in 2026.
- Business Quant data shows ABSI's Other Non-Current Assets at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $16.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | 1.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.06 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 16.34 Mn |
| Jun 30, 2025 | 716,000.00 |
| Mar 31, 2025 | 631,000.00 |
| Dec 31, 2024 | 15.95 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 16.51 Mn |
| Mar 31, 2024 | 1.53 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 15.07 Mn |
| Mar 31, 2023 | 1.88 Mn |
| Dec 31, 2022 | 1.86 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.85 Mn |
| Mar 31, 2022 | 1.84 Mn |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | 10.51 Mn |
| Jun 30, 2021 | 2.82 Mn |